Loading viewer...
earnings
Format: PDF earnings
TTM Technologies reported Q2 2024 earnings results with revenue of $605.1M exceeding guidance and non-GAAP EPS of $0.39. The company achieved strong operational cash flow of $41.9M and maintained a robust cash balance of $446.2M with net leverage at 1.4x. Management provided Q3 2024 guidance and announced refinancing of its Term Loan B facility at improved rates.
Teva Pharmaceutical Q2 2023 Earnings Results
earningsearnings
54 Pages
Teva Pharmaceutical Industries Ltd.
presentation
earnings
35 Pages
Fletcher Building
FIS Fourth Quarter 2016 Earnings Call
earningsearnings
33 Pages
Fidelity National Information Services